Latest News on Roche
Showing of 0 - 10 from 6 results
Roche - Total results - 6
Sep 08, 2015
Another setback: India rejects patent on Pfizer's arthritis drugPfizer is reviewing its options for further action, a Mumbai-based company spokesman said in an emailed statement.
Aug 25, 2014
All-cash deal: Roche to buy US biotech firm InterMune for $8.3 bnRoche Holding AG has agreed to buy US biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.
Jan 18, 2014
Biocon to start selling breast cancer drug next monthCANMAb will be available at about 25 percent discount to the current list price of the reference product - Roche's Herceptin - in India, which is already significantly lower than its price in developed markets, it added.
Aug 08, 2013
Not just India: UK regulator says Roche’s new breast cancer drug too costlyThe National Institute for Care and Excellence (NICE) of the UK has rejected Roche’s latest breast cancer drug Perjeta because it is too expensive.
Nov 03, 2012
India revokes Roche patent; questions high price of drugThe Intellectual Property Appellate Board (IPAB) cited a lack of evidence that the drug was any better than existing treatments and its high price as reasons for the decision.
Sep 05, 2007
TCS Collaborates With RocheTCS has entered into a collaboration with Swiss healthcare company Roche to provide services related to drug development processes.